Orelabrutinib, Placebo tablets match with that of orelabrutinib (ICP-022) tablets in appearance, shape, size, and weight. clinical trials

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis

This study is testing a new medicine, orelabrutinib, for people with a type of multiple sclerosis called Primary Progressive MS (PPMS). We want to see if it can slow down the worsening of symptoms compared to a dummy pill (placebo).